Literature DB >> 2452307

Different interaction of bepridil and diltiazem with BAY K 8644 in the abolition of autoregulation of renal blood flow.

N Ogawa1, S Yokota, H Ono.   

Abstract

The effect of bepridil and diltiazem on autoregulation of renal blood flow was examined in connection with interaction of BAY K 8644 in perfused kidney of anesthetized dogs. When the perfusion pressure was changed stepwise over the range between 60 and 200 mm Hg, renal blood flow remained nearly constant between 100 and 200 mm Hg. Intra-arterial infusion of diltiazem (50 microgram/min) or bepridil (1 mg/min) increased renal blood flow at perfusion pressure above 100 mm Hg and completely inhibited renal autoregulation. Simultaneous infusion of 5 microgram/min of BAY K 8644 with diltiazem antagonized both the increase of renal blood flow and the impairment of autoregulation, whereas simultaneous infusion of BAY K 8644 (5 micrograms/min) could not block the impairment of renal autoregulation induced by bepridil. These results show that the inhibitory effect of bepridil on autoregulation of renal blood flow is due to some mechanism other than Ca channel blocking action in renal vasculature.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452307

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  3 in total

Review 1.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

2.  Renal blood flow and dynamic autoregulation in conscious mice.

Authors:  Radu Iliescu; Radu Cazan; Gerald R McLemore; Marcia Venegas-Pont; Michael J Ryan
Journal:  Am J Physiol Renal Physiol       Date:  2008-06-25

Review 3.  Calcium Channel Blockers in Acute Care: The Links and Missing Links Between Hemodynamic Effects and Outcome Evidence.

Authors:  Jin Wang; David L McDonagh; Lingzhong Meng
Journal:  Am J Cardiovasc Drugs       Date:  2021-01       Impact factor: 3.571

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.